While 2020/2021 has been a turbulent year for many industries, the insurance broker M&A market has remained active and buoyant. In part, due to an increased need for the surety that insurance offers in unpredictable times, the demand for premiums has risen.
As investors look to resilient markets and businesses with healthy recurring revenues to stabilise their portfolios, insurance has become a key target for M&A activity. As the volume of M&A activity continues to increase, it is a good time for brokerages of all sizes to evaluate their exit options.
Morphose has unique expertise in advising clients in the insurance sector to optimise their exit options and ultimately sale price. Most recently working with Borland Insurance on its 2021 sale to US Broker AssuredPartners, Morphose helps businesses to identify the right acquisition partner and works with them ever step of the way to achieve their exit goal.
Morphose runs regular online advisory clinics for companies wishing to explore their exit options. For more information please do get in touch.